Freesolve Magnesium Scaffold for Heart Artery Blockages
Part of Brain & nervous system, Heart & circulation, Pain clinical trials.
This trial tests a new dissolvable magnesium scaffold to treat blockages in heart arteries. It is designed for people with stable heart pain or certain recent heart attacks, and it aims to open blocked arteries and then slowly dissolve over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have stable heart pain (angina) or had a mild heart attack without ongoing damage, or had a more serious heart attack at least 72 hours ago and are now stable.
- You are willing to take two blood-thinning medicines (aspirin plus another one) for at least one month.
- You have no severe kidney problems, bleeding disorders, or allergies to the scaffold materials or required medicines.
- You have no blockages in the main left heart artery or in a previous bypass graft, and the target blockages are short enough (≤ 36 mm) to be covered by one scaffold.
- You have not had a stroke in the last 6 months or a planned surgery within 6 months that would interfere with blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This is a registry study that follows people who receive a resorbable magnesium scaffold (a temporary artery support used during procedures). The goal is to learn how the device performs and how patients do over time in real-world use.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This study tests a new way to treat long, narrow blockages in the heart's arteries. It combines a temporary scaffold with a drug-coated balloon, which may help the artery heal without a permanent metal stent. This could be an option for people who need their artery opened but may benefit from a less permanent approach.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
Hear when a new Coronary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.